| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- manufacturers
- BAY 73-1449
-
- $37.00
-
2026-09-10
- CAS:693790-96-4
- Purity: 99.77%
- Supply Ability: 10g
|
| | D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- Basic information |
| Product Name: | D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- | | Synonyms: | D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]-;BAY 73-1449;vessel,portal,pressure,mesenteric,porto-systemic,inhibit,BAY 731449,blood,BAY 73 1449,prostacyclin,inflow,BAY 73-1449,splenic,Inhibitor,shunt,lower,Prostaglandin Receptor,outflow;BAY 73-1449, 10 mM in DMSO | | CAS: | 693790-96-4 | | MF: | C26H23N3O3 | | MW: | 425.48 | | EINECS: | | | Product Categories: | | | Mol File: | 693790-96-4.mol | ![D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- Structure](CAS/20210111/GIF/693790-96-4.gif) |
| | D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- Chemical Properties |
| Boiling point | 700.4±60.0 °C(Predicted) | | density | 1.273±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: 250 mg/mL (587.57 mM) | | pka | 3.35±0.10(Predicted) | | form | Solid | | color | White to off-white |
| | D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- Usage And Synthesis |
| Uses | BAY 73-1449 is a selective antagonist of prostacyclin receptor (IP), with high potency (IC50 of less than 0.1 nM) in cAMP assays in Human HEL cells and rat DRG. BAY 73-1449 can be used in the research of lowering blood pressure[1]. | | in vivo | BAY 73-1449 (0.1-1 mg/kg; i.v.) does not significantly reduce mesenteric inflow, but significantly reduces splenic shunt vessel outflow in rats[1].
BAY 73-1449 (1-5 mg/kg, s.c. once daily for 7 d) has no effects on the degree of porto-systemic shunting in rats[1].
BAY 73-1449 (1 mg/kg, s.c. once daily for 7 d), has no effects on portal pressures in rats[1]. | Animal Model: | Male Wistar rats (250-350 g) are ligated portal vein[1] | | Dosage: | 0.1, 1 mg/kg | | Administration: | A single i.v. | | Result: | Significantly reduced shunt flow without affecting mesenteric flow. |
| | IC 50 | IP Receptor: <0.1 nM (IC50) | | References | [1] Bexis S, et, al. Vascular actions of the prostacyclin receptor antagonist BAY 73-1449 in the portal hypertensive rat. Eur J Pharmacol. 2008 Aug 20;590(1-3):322-6. DOI:10.1016/j.ejphar.2008.06.006 |
| | D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- Preparation Products And Raw materials |
|